T1 Condition 551 554 AAD
T2 Protein 1036 1040 drug
T3 Protein 210 215 lipid
T4 Condition 281 284 AAD
T5 Condition 139 142 AAD
T6 Protein 37 41 drug
T7 Condition 681 709  that stimulates cancer cell
T8 Condition 43 46 AAD
T9 Condition 421 426 tumor
T10 Condition 311 316 tumor
T11 Condition 86 101 cancer patients
T12 Biomarker 665 675 fatty acid
T13 Intervention 520 532 microvessels
T14 Biomarker 591 601 fatty acid
T15 Condition 409 427 AAD-treated tumors
T16 Level 811 827 FFA-induced cell
T17 Condition 904 907 AAD
T18 Condition 86 92 cancer
T19 Condition 394 397 AAD
T20 Condition 195 198 AAD
T21 Protein 775 779 CPT1
T22 Protein 879 883 CPT1
T23 Protein 349 356 adipose
T24 Protein 333 369 adipose and non-adipose environments
T25 Gene 739 773 carnitine palmitoyl transferase 1A
T26 Gene 843 850 Genetic
T27 Condition 698 704 cancer
T29 Protein 431 438 adipose
T30 Intervention 236 249 reprogramming
T31 Protein 333 340 adipose
T32 Condition 551 568 AAD-induced tumor
T33 Condition 951 956 tumor
T34 Condition 409 412 AAD
T35 Protein 107 116 molecular
T36 Protein 1071 1076 lipid
T37 Intervention 622 635 reprogramming
T38 Condition 1000 1006 cancer
R1 Relation Arg1:T30 Arg2:T10
